Kronos Bio Reports Fourth Quarter and Full Year 2024 Financial Results
Kronos Bio, Inc. (Nasdaq: KRON), a biopharmaceutical company, today reported fourth quarter and full year 2024 financial results. Fourth Quarter and Full Year 2024 Financial Results Cash, cash equivalents and investments: Cash,
Crescita Reports Q4 and Fiscal 2024 Results
Crescita Therapeutics Inc. ( TSX: CTX and OTC US: CRRTF) (“Crescita” or the “Company”), a growth-oriented, innovation-driven Canadian commercial dermatology company, today reported its financial results for the fourth quarter and fiscal year ended December 31,
Q4 2024 Earnings Call Transcript March 17, 2025 Operator: Good morning, everyone, and welcome to the Inspired Entertainment ...
MediWound (NASDAQ:MDWD) is scheduled to announce Q4 earnings results on Wednesday, March 19th, before market open. The consensus EPS Estimate is -$0.61 (-221.1% Y/Y) and the consensus Revenue Estimate ...
This improvement reflects the successful execution of our strategic initiatives throughout 2024, which has positioned us to better navigate the challenging retail environment while delivering ...
Q4 2024 Earnings Call Transcript March 17, 2025 Operator: Good morning. At this time, I would like to welcome everyone to the Creative Realities 2024 Fourth Quarter Earnings Conference Call. This call ...
Kingsoft Cloud (NASDAQ:KC) is scheduled to announce Q4 earnings results on Wednesday, March 19th, before market open. The consensus EPS Estimate is -$0.11 (-1000.0% Y/Y) and the consensus Revenue ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback